{"transactions":[{"id":1869124,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T20:36:54.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":10.34,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-23-012775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299323012775/form4.xml","form_type":"4"}},{"id":1869123,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:36:54.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":6270,"source":{"system":"sec-edgar","filing":"0001062993-23-012775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299323012775/form4.xml","form_type":"4"}},{"id":1915602,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Fmr. Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-21T21:45:03.000Z","date":"2022-10-03","kind":"sale","planned":true,"acquired":false,"shares":7,"price":7,"value":49.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan."}],"balance_after":87148,"source":{"system":"sec-edgar","filing":"0001578563-23-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000026/primary_doc.xml","form_type":"4"}},{"id":1915601,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Fmr. Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-21T21:45:03.000Z","date":"2022-07-01","kind":"sale","planned":true,"acquired":false,"shares":95,"price":6.73,"value":639.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan."}],"balance_after":87155,"source":{"system":"sec-edgar","filing":"0001578563-23-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000026/primary_doc.xml","form_type":"4"}},{"id":1915600,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Fmr. Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-21T21:45:03.000Z","date":"2022-04-01","kind":"sale","planned":true,"acquired":false,"shares":40,"price":14.07,"value":562.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,398 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan.  This number has also been adjusted to account for a scrivener's error in a prior filing which attributed an acquisition of 40 shares under the Company's 2021 Employee Stock Purchase Plan."}],"balance_after":87250,"source":{"system":"sec-edgar","filing":"0001578563-23-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000026/primary_doc.xml","form_type":"4"}},{"id":2247003,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:07:51.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":6.84,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-22-014133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322014133/form4.xml","form_type":"4"}},{"id":2247002,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:07:51.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":3135,"source":{"system":"sec-edgar","filing":"0001062993-22-014133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322014133/form4.xml","form_type":"4"}},{"id":2304473,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-06T01:14:46.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":106485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The RSUs vested on April 1, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested on April 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested on April 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":106485},"source":{"system":"sec-edgar","filing":"0000899243-22-013963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013963/doc4.xml","form_type":"4"}},{"id":2304472,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-06T01:14:46.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":65963,"price":11.1199,"value":733501.9637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects shares sold to cover taxes upon the vesting of RSUs on April 1, 2022 pursuant to a standing 10b5-1 instruction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.48, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":83932,"source":{"system":"sec-edgar","filing":"0000899243-22-013963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013963/doc4.xml","form_type":"4"}},{"id":2304471,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-06T01:14:46.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":106485,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40 shares acquired under the Company's 2021 Employee Stock Purchase Program on April 1, 2022."}],"balance_after":149895,"source":{"system":"sec-edgar","filing":"0000899243-22-013963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322013963/doc4.xml","form_type":"4"}},{"id":2394508,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-16T02:17:44.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":1470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested on February 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested on February 11, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1470},"source":{"system":"sec-edgar","filing":"0000899243-22-006538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006538/doc4.xml","form_type":"4"}},{"id":2394507,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-16T02:17:44.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":534,"price":11.9875,"value":6401.325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 11, 2022 pursuant to a standing 10b5-1 instruction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.87 to $11.99, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":43370,"source":{"system":"sec-edgar","filing":"0000899243-22-006538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006538/doc4.xml","form_type":"4"}},{"id":2394506,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-16T02:17:44.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":1470,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":43904,"source":{"system":"sec-edgar","filing":"0000899243-22-006538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006538/doc4.xml","form_type":"4"}},{"id":2398021,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Phantom Profit Units","published_at":"2022-02-15T01:41:58.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":66139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":66139},"source":{"system":"sec-edgar","filing":"0000899243-22-006332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006332/doc4.xml","form_type":"4"}},{"id":2398020,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2022-02-15T01:41:58.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":true,"shares":24205,"price":12.88,"value":311760.4,"ownership":{"direct":true},"balance_after":42434,"source":{"system":"sec-edgar","filing":"0000899243-22-006332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006332/doc4.xml","form_type":"4"}},{"id":2398019,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2022-02-15T01:41:58.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":66139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering."}],"balance_after":66639,"source":{"system":"sec-edgar","filing":"0000899243-22-006332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924322006332/doc4.xml","form_type":"4"}},{"id":2680474,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T21:08:42.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments on the second day of each of the 36 calendar months immediately following June 2, 2021, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8000,"derivative":{"exercise_price":13.16,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001192482-21-000493","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248221000493/edgar.xml","form_type":"4"}},{"id":2757919,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-05T20:31:18.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":106485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on April 1, 2022 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on April 1, 2022 and have no expiration date."}],"balance_after":106485,"derivative":{"underlying":"Class A Common Stock","underlying_shares":106485},"source":{"system":"sec-edgar","filing":"0000899243-21-014832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321014832/doc4.xml","form_type":"4"}},{"id":2757918,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-04-05T20:31:18.000Z","date":"2021-02-11","kind":"purchase","acquired":true,"shares":500,"price":13,"value":6500.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0000899243-21-014832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321014832/doc4.xml","form_type":"4"}},{"id":2859116,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":112791,"kind":"person","name":"Nosenzo John","position":1,"cik":"0001835973","reported_name":"Nosenzo John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-16T23:14:42.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":1470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on February 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on February 11, 2022."}],"balance_after":1470,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1470},"source":{"system":"sec-edgar","filing":"0000899243-21-006750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321006750/doc4.xml","form_type":"4"}}]}